Methods of using pegylated interleukin-10 for treating cancer
First Claim
Patent Images
1. A method of treating cancer in a human subject, comprising administering to the human subject a therapeutically effective amount of a PEG-IL-10 agent sufficient to maintain an IL-10 serum trough concentration of the PEG-IL-10 agent in the human subject at or above 1 ng/ml over a period of time of at least one week;
- wherein said administering treats cancer in the human subject.
2 Assignments
0 Petitions
Accused Products
Abstract
Methods of treating subjects having a disease or disorder responsive to IL-10, including methods of administration and dosing regimens associated therewith, are provided.
103 Citations
16 Claims
-
1. A method of treating cancer in a human subject, comprising administering to the human subject a therapeutically effective amount of a PEG-IL-10 agent sufficient to maintain an IL-10 serum trough concentration of the PEG-IL-10 agent in the human subject at or above 1 ng/ml over a period of time of at least one week;
- wherein said administering treats cancer in the human subject.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)
Specification